Skip to content
If innovation is nurtured carefully, biotechnology in food, agriculture, and manufacturing could grow to contribute $416 billion to the U.S. economy by 2030, says […]
Report: Unleashing bioeconomy’s huge potential requires regulatory updates Read More »
As part of BIO’s March Patient Advocacy Coffee Chat, Thomas Heymann, President & CEO of Sepsis Alliance, spoke about sepsis—a life-threatening condition caused by
Sepsis and AMR: Understanding the connection and the growing threat to public health Read More »
Despite women making up half the population, women’s health has historically been “woefully underfunded,” accounting for less than 5% of products in the biotech
Women’s History Month: What’s the story with women’s health investment? Read More »
Patient perspectives are vital to inform health policy. One agency where such input is particularly crucial is the Centers for Medicare and Medicaid Services
Patient organization engagement of CMS is more important than ever Read More »
Biotechnology and agriculture have evolved together. Since humanity first started farming, we have been working to impact soil, plants, animals, and microbes to secure
National Agriculture Day: Biotech and agriculture grow together Read More »
The Food and Drug Administration’s (FDA) Rare Pediatric Disease Priority Review Voucher (PPRV) Program was top of mind during BIO’s March Patient Advocacy Coffee
Whether it’s bottles, baby wipes, fashion, or fuel, biology can build it better. Biobased products, made from renewable natural materials, provide sustainable alternatives to
National Biobased Products Day: Building better with biology Read More »
March 8th is International Women’s Day and to mark the occasion, Bio.News is exploring an under researched field of women’s health – autoimmune diseases
International Women’s Day: Improving women’s health by addressing autoimmune disease Read More »
The time has come for Congress to pass legislation to prevent pharmacy benefit managers (PBMs) from inflating drug costs, limiting patient access to drugs,
House members urge passage of reforms at PBM hearing Read More »
Bipartisan legislation reintroduced in the House on Feb. 21 would encourage the development of small-molecule drugs by eliminating the “pill penalty” in the Inflation
EPIC Act introduced to correct IRA’s ‘pill penalty’ Read More »
